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A variety of mechanisms are used to signal extracytoplasmic conditions to the cytoplasm. These mechanisms activate extracytoplasmic
function (ECF) sigma factors which recruit RNA-polymerase to specific genes in order to express appropriate proteins in response to the changing
environment. The two best understood ECF signaling pathways regulate σE-mediated expression of periplasmic stress response genes in
Escherichia coli and FecI-mediated expression of iron–citrate transport genes in E. coli. Homologues from other Gram-negative bacteria suggest
that these two signaling mechanisms and variations on these mechanisms may be the general schemes by which ECF sigma factors are regulated in
Gram-negative bacteria.
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Bacteria live in an ever-changing environment and must alter
protein expression on their cell surface to adapt to these changes
and survive. Environmental changes include the following:
osmolarity [1], membrane composition [2], light [3], barometric
pressure [1], temperature [4,1], and the concentration of some
nutrients, e.g. chelated iron (III) [5]. Bacteria have developed
sets of specific response genes that are regulated by a subset of
the σ70-like sigma factors in order to respond to a changing
environment. Given a specific external stimulus, these sigma
factors recruit RNA polymerase to the appropriate response
genes. As these sigma factors are involved in regulating the
expression of proteins residing in the outer membrane or
periplasmic space, they are given the moniker extracytoplasmic
function (ECF) sigma factors [6].
Because the exterior of invasive bacteria comes into contact
with the host and must respond to the host environment, ECF
sigma factors also regulate genes associated with bacterial
virulence. Lethality of Mycobacterium tuberculosis in mice is
dependent on the ECF sigma factor σC [7]. The activity of
Escherichia coli σE is involved in uropathogenesis [8]. The
virulence of Salmonella typhimurium is also dependent on σE
[9]. Notably, the ECF σE homologue AlgU regulates the ex-
pression of the mucoid envelope that protects Pseudomonas
aeruginosa from antibiotics, oxidative stress, and immune
attack [10]. This mucoid form of the bacteria is also associated
with morbid and mortal infectivity in the lungs of cystic fibrosis
patients [11].
Some bacterial pathogens are known to express virulence
genes in low iron environments [12–14]. The virulence of
some bacteria in animal models is associated with iron-
binding siderophores that facilitate iron uptake [15]. The iron-
siderophore pyoverdine and signaling through its associated
TonB-dependent ferro-pyoverdine receptor (PvdA) are asso-
ciated with virulence in P. aeruginosa [16,17]. These genes
are regulated by ECF sigma factor PvdS [16,17].
In order to communicate the conditions of the periplasm or
the outside environment to the genetic machinery of the cell, a
signal must pass through one or two bacterial membranes to the
cytoplasm. Thus, signaling to the ECF sigma factors must
involve integral membrane proteins to achieve this commu-
nication. In many bacterial signaling pathways, transmembrane
signaling is achieved with a two-component signaling mechan-
ism, in which a membrane-bound receptor phosphorylates a
cytoplasmic effector. Two-component signaling is the subject of
another review in this volume. Sequence homology indicates
that two-component signaling activation of an ECF sigma factor
may regulate the activity of σE from the Gram-positive
bacterium Streptomyces coelicolor A3(2) [18]. However, to
date, this has not been seen in Gram-negative bacteria and thus
two-component signaling in ECF activation may be limited to
Gram-positive bacteria. In the basal state, all known ECF sigma
factors in Gram-negative bacteria interact with an anti-sigma
factor that inhibits the associated ECF sigma factor from
interacting with RNA polymerase [19]. The ECF signaling
mechanisms presented here illustrate different methods ofsignaling and different roles for the anti-sigma factor in
regulation of sigma factor activity.
Sequence similarity and functional studies suggest that most
ECF sigma factors are likely to be regulated by a mechanism
similar to either the activation mechanism of the periplasmic
stress response sigma factor, σE, or the activation mechanism of
the iron–citrate response sigma factor, σFecI (FecI), both from
E. coli. Inhibition of σE is relieved by signals from the peri-
plasm that stimulate the complete degradation of its anti-sigma
factor. In FecI activation, extracellular signals travel though a
protein network across two membranes and the periplasmic
space in order to alter the usual anti-sigma factor role; the anti-
sigma factor of FecI also plays an important role in activating
FecI. In this review, we discuss the two major groups of ECF
sigma factor associated signaling mechanisms, represented by
the σE and the FecI systems.
2. Stress response genes in E. coli: activation of ECF sigma
factor σE
σE is an essential gene that controls the periplasmic heat
shock regulon that is activated by unfolded protein in the
periplasm [5,20]. The accumulation of unfolded proteins can be
caused by a number of factors: heat, overproduction of outer
membrane protein C (OmpC) or other outer membrane proteins
(OMPs) [21,22], altered lipopolysaccharide in the outer
membrane [23], or mutations in folding enzymes such as the
Dsb proteins and prolyl isomerases [2,24]. About 20 promoters
are transcribed in a σE-dependent manner [25]. The expressed
proteins include OMP-folding chaperones, lipopolysaccharide
biogenesis enzymes, and periplasmic proteases [25]. The genes
regulated by σE also include the cytoplasmic heat shock protein
σ32, the house keeping sigma factor σ70, as well as σE itself
with all of its regulatory components (RseA, RseB, RseC and
RseP) [25].
Recent discoveries indicate that the σE regulon also contains
small RNA (sRNA) transcripts that lower the expression of a
number of outer membrane proteins in an Hfq-dependent man-
ner. Hfq functions as a molecular match-maker in facilitation of
sRNA–mRNA interactions [26–28]. σE-regulated expression
of the sRNA RybB results in decreased levels of mRNAs
encoding OmpC, OmpA, and OmpW [27,29]. Similarly, σE-
dependent up regulation of MicA negatively affects the
expression of OmpA [27,29]. Hfq regulates σE itself as well
as a number of other genes in the σ32 and σS stress response
pathways, which suggest that Hfq may play a pivotal role in
regulating all of these different stress response pathways [29].
The general scheme for regulation of σE is through sti-
mulated and regulated intramembrane proteolysis (RIP) of its
anti-sigma factor RseA (Fig. 1). The use of RIP is a common
mechanism for communication found in both eukaryotes and
prokaryotes (for a review, see [30]). This mechanism can be
used to signal across membranes in either direction. Generally
the RIP protease activity is regulated through a specific signal-
dependent proteolytic cleavage of a soluble portion of the
substrate protein on one side of the membrane (Site 1). After
this cleavage, the RIP protease is free to cleave the substrate
Fig. 1. Mechanism of σE activation.① The PDZ domain of DegS recognizes the CTD of an unfolded outer membrane protein.② The activated DegS protease domain
cleaves RseA at Site 1, thus relieving inhibition imposed by RseB on RseP activity through the glutamine-rich domains of RseA and the PDZ domain of RseP.③ RseP
acts as RIP protease and cuts RseA near the cytosolic side of the membrane (Site 2).④ ClpXP and other ATP driven proteases remove RseA from σE.⑤ σE binds the
β′ subunit of RNA polymerase and directs it to the appropriate promoter sites. This figure and Figs. 2, 7, and 8) were prepared with Adobe Illustrator.
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a protein fragment on the other side of the membrane. This
protein fragment often serves as a signal in eukaryotic systems.
In the case of σE, the substrate of the RIP protease is ultimately
completely eliminated in order to free σE.
RseA spans the inner membrane and includes both a
cytoplasmic σE-inhibitory domain and a periplasmic regula-
tory domain. Destruction of RseA and consequent relief of σE
inhibition is regulated by both DegS and RseP, both of which
are inner membrane proteins and proteases. The protease
activity of DegS is activated on recognition of the C-termini of
unfolded OMPs, and upon activation, DegS cleaves off a
periplasmic portion of RseA [22,31,32]. As a consequence,
inhibition of the RIP protease RseP (or YaeL) is relieved and it
cleaves RseA in the inner membrane proximal to the
cytoplasmic side [33–35]. The liberated RseA continues toFig. 2. Comparison of the domain structures of ECF (Group IV) sigma factors and Gro
are missing form ECF sigma factors. The ECF sigma factors only have two globulainhibit σE until ClpXP and other ATP driven cytoplasmic
proteases separate the RseA/σE complex and degrade RseA
[20,36,37].
2.1. RseA as anti-sigma factor
Like all ECF (also called Group IV) sigma factors, σE is
significantly different from the prototypical, Group I σ70
proteins [19]. The ECF sigma factors are evolutionarily the
most divergent of the σ70 proteins [6]. Of the four domains
or regions observed in Group I sigma factors, the N-terminal
subdomain (σ1.1) is missing and much of the third region (σ3)
is missing in ECF sigma factors (Fig. 2) [6,38,39]. Further-
more, in ECF sigma factors, regions 1 and 3 (σ1 and σ3) have
lower conservation and are acidic, whereas regions 2 and 4
(σ2 and σ4) are highly conserved and are more basic [38].up I sigma factors. The 1.1 region, non-conserved region (NCR), and much of σ3
r domains compared to the three of Group I sigma factors [121,39].
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promoter, respectively [40]. The σ1 region prevents sigma
factors from binding to the promoter without RNA polymerase,
and the truncation in ECF sigma factors may allow promoter
binding without RNA polymerase [6,41,42]. FliA, an ECF
sigma factor that lacks the 1.1 region, can bind its promoter
independently of the presence of RNA polymerase [42].
However, RNA polymerase is still required for DNA binding
by the ECF sigma factor FecI [43]. Region σ3 allows sigma
factors to recognize promoters with extended −10 elements,
thus ECF sigma factors should be deficient in this ability [44].
Despite the overall differences between Group I sigma factors
and the ECF sigma factors, an X-ray crystal structure of σE
indicates that σ2 and σ4 are essentially identical to those
regions in the Group I sigma factors [39,44–47]. The two-
domain architecture of the ECF sigma factors likely represents
the minimal structure required for σ factor activity [39].
The X-ray crystal structure of the complex of a cytosolic
fragment of RseA and σE reveals the mechanism of strong
inhibition of σE by RseA. The structure shows that the anti-
sigma factor is sandwiched between σ2 and σ4 of σ
E (Fig. 3)
[39]. In total, the complex buries 3805 Å2 of surface with
hydrophobic interactions dominating [39]. Although interac-
tions between σ2 and σ4 dominate, the spacing provided by the
flexible linker region is important for binding [39]. Experi-
mentally induced proteolysis of the RseA/σE complex illus-
trated the overall protection from proteolysis that is afforded
by RseA and generated σ2 and σ4 as individual cleavage pro-
ducts, which can bind to RseA individually [39]. This domi-
nance of σ2 and σ4 interactions with RseA is consistent with
the effects of point mutations that interfere with RseA–σE
complex formation [39].
RseA inhibits σE activity by interfering with the formation of
the σE–RNA polymerase complex. σE cannot compete with σ70
for RNA polymerase in the presence of RseA [39]. In order to
identify exactly how RseA inhibits the binding of σE to RNA
polymerase, Campbell et al. used the similarity of regions σ2 and
σ4 to σ
A and σE, to model a σE–RNA polymerase holoenzymeFig. 3. X-ray crystal structure illustrating the interaction between RseA (yellow)
and σE (blue (σ2) and red (σ4)) [39]. RseA helices α3 and α4 clash with portions
of RNA polymerase to inhibit binding to σE. This figure, and Figs. 4–6, 9, and
10 were prepared with PYMOL [129].based on the σA–RNA polymerase holoenzyme structure. With
this model, the authors predicted steric clashes between ele-
ments of RseA and the primary binding determinants of RNA
polymerase (Fig. 3). The σ2:β′ coiled-coil interaction between
σE and RNA polymerase is incompatible with RseA binding
because α-helix 4 of RseA would clash with the β′ coiled-coil
structure [39]. Similarly, α-helix 3 of RseA sterically clashes with
the β flap-tip helix that is involved in interaction of σ4 with σ
E
[39].
2.2. Regulation of the DegS proteolysis of RseA
In order to liberate σE from RseA, a single cut by DegS
initiates a series of proteolytic modifications of RseA that
ends in its complete degradation. This initial proteolytic step
is the critical and only known positively regulated proteolytic
event in the regulation of σE. In wild-type E. coli, DegS is
required for σE activity and is essential to the cell [22].
Without DegS, σE activity can no longer be induced in res-
ponse to extracytoplasmic stress [22]. DegS recognizes the
three terminal amino acids in denatured OMPs, which is a
good indicator of the folded state of OMPs, as the C-terminal
residues are normally sequestered in the lipid bilayer
[32,37,48]. Although DegS prefers YYF or YYM, DegS
also recognizes YXF which is found in OmpC and in other
known and putative OMPs [32]. Recognition of peptides with
these sequences activates DegS to become proteolytically
active and cleave the periplasmic domain of RseA between
residues 148 and 149 (Fig. 1, Site 1) [32]. These residues in
RseA are separated from the periplasmic side of the inner
membrane by about 30 residues, which places the cleavage
site far enough from the membrane to be cleaved by DegS
[32].
DegS belongs to the HtrA family of oligomeric serine
proteases (for reviews, see [49,50]). One aspect of the HtrA
family members is that at least one PDZ domain accompanies
each of their defined catalytic domains. PDZ domains are
involved in the mediation of specific protein–protein interac-
tions in both eukaryotes and prokaryotes (for a review, see [51]).
In most cases, PDZ domains recognize the very C-terminal end
of the partner protein. Generally, only 6–10 amino acids are
necessary and sufficient for binding affinity equal to that of the
full-length protein [51].
The crystal structures of the soluble portion of DegS with
and without a peptide that consists of the C-terminal residues
of OmpC illustrate how the PDZ domain of DegS functions to
specifically activate DegS protease activity [52]. The PDZ
domain links the recognition of specific unfolded proteins to
allosteric activation of the proteolytic activity towards RseA.
Like other HtrA family proteins, DegS is a single pass inner
membrane protein that extends into the periplasm of the cell
where the soluble portions of the protein interact to form a
trimer [49,50]. The periplasmic portion of DegS forms the
shape of a pinwheel consisting of a core of the three
proteolytic domains, each accompanied by a PDZ domain
(Fig. 4) [52]. Similar to other known crystal structures of PDZ
domains with peptide ligands, the last four residues of the
Fig. 5. Illustration of loop movements that cause protease domain activation on
the binding of a peptide mimicking the OmpC C-terminus (orange). DegS (apo
DegS in yellow and peptide bound DegS in green) loops 2 and 3 move towards
the protease active site serine (S201) on ligand binding. These movements cause
a number of changes in other loops including L1 and LD. The resultant changes
remove obstructing residues from the substrate binding pocket and improve the
geometry of the active site residues.
Fig. 4. Crystal structure of DegS with OmpCCTD peptide [52]. A subunit of the
DegS trimer is shown in purple (protease domain) and light blue (PDZ domain).
The interacting OmpCCTD is shown in orange. The remaining subunits are
shown in green.
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an additional β-strand at the end of the β-sheet in the PDZ
domain [52–54].
A comparison of the peptide-bound and peptide-free struc-
tures of DegS reveals a series of conformational changes in
loops L1, L2, L3, and LD (Fig. 5). Loop 2 is important for
substrate recognition, and L1 and LD are loops important to
the DegS protease activity [52]. The allosterically driven
changes in loop L2 remove residue L218 from the S1
substrate recognition site thus allowing it to recognize RseA
(Fig. 6) [52]. The LD and L1 loop movements are critical to
the backbone conformational change observed in residue
H198 (Fig. 6). This residue reorients the main chain carbonyl
and its associated partial negative charge from a position
pointing into the positively charged “anion hole” of the active
site to a position pointing away from the active site. The
conformational change of this carbonyl removes inhibition on
the protease activity of DegS [52]. Furthermore, the geometry
between H96 and S201 of the catalytic triad (S201, D126,
and H96) improves on peptide binding. Thus, the PDZ
domain-mediated binding of the C-terminal tails of unfolded
outer membrane proteins stimulates the proteolytic activity of
DegS.
2.3. Regulation of RseP and preservation of the sequential
proteolysis of RseA
On DegS cleavage of the periplasmic domain from RseA,
RseP can access the second site of proteolysis (Fig. 1, Site 2),
which lies in the inner membrane spanning portion of RseA
[33,34]. RseP is an intramembrane protease that belongs to the
family of RIP proteases founded by the S2P protease gamma-
secretase [55,56]. These proteases have multiple membrane-spanning regions and include the typical metalloprotease motif
HEXXH and a C-terminal LDG motif (Fig. 7) [30,57,58].
RseP appears to consist of four transmembrane domains with
a PDZ protein interaction domain in a periplasmic loop
connecting the second and third transmembrane helices [56].
Mutations of the HEXXH and LDG regions of RseP eli-
minate protease activity [56]. The labeling and functional
assays indicate that the RseP protease active site appears to be
in a highly structured part of the protein at the interface of the
cytosolic side of the inner membrane [56].
In order for DegS proteolysis to be the rate limiting step in
the proteolytic cascade of RseA degradation, substrate acces-
sibility to the active site of RseP must be highly regulated.
Before cleavage by DegS occurs, the periplasmic domain of
RseA inhibits RseP from proteolysis of RseA. The proteolysis
of RseA by DegS removes the inhibition of proteolysis of RseA
by RseP [33,34]. After the initial cut by DegS, the subsequent
proteolysis is so rapid that the DegS cleavage product of RseA
is not normally detected [33,34,37].
Direct or indirect interactions between the PDZ domain of
RseP and the glutamine-rich domain of RseA inhibit the
activity of RseP [35]. RseA has two periplasmic glutamine-
rich domains (residues 162–169 and 190–200) that are both
necessary to confer wild-type resistance of RseA to RseP
proteolysis [35]. The PDZ domain of RseP also confers inhi-
bition of the proteolysis of RseP [35,59]. As PDZ domains
can recognize internal sequences as well as terminal
sequences, the glutamine-rich domains of RseA may be re-
cognized by the PDZ domain of RseP in order to create an
inhibitory protein–protein interaction. The mode of inhibition
through this interaction is not known but one may speculate
that this interaction could position the RseA and RseP in an
Fig. 6. Comparison of the two states of DegS to β-trypsin with a monoisopropyl phosphate (MIP) modified active site serine. The modifying moiety occupies the
substrate binding site and catalytic site. (A) Leucine 218 blocks the substrate binding site in the Apo DegS (pink) structure as shown by clashing with the MIP moiety
on β-trypsin (yellow with black text). The carbonyl of DegS (pink) His198 points into the active site as compared to the N192 carbonyl of β-trypsin that is in a
catalytically active position. (B) When DegS has bound an OmpC C-terminal peptide, L218 no longer interferes with substrate binding and the carbonyl of H198 is in a
catalytically active orientation.
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protein interaction would keep the protease proximal for
quick activity once the first protease site in RseA is cleaved.
This interaction may also prevent more indiscriminant activity
of RseP, as it has an unexpectedly wide substrate specificity
[55].
Grigorova et al. illustrate how negative regulation of RseP
enforces the sequential degradation of RseA and enforces the
design features apparent in the σE activation pathway [60]. σE
activity is both sensitive to a wide range of OMP signals [21]
and insensitive to variable concentrations of DegS and RseP
[33]. RseB inhibits the proteolysis of RseA by RseP when
RseB is bound to the periplasmic domain of RseA [60].
Without RseB, RseP can cleave full-length RseA and allow
activation of σE in the absence of DegS [60]. Furthermore,
without RseB this cleavage is now dependent on the
concentration of RseP [60]. However, in wild-type E. coli,
the response to unfolded OMPs is completely dependent on
DegS. Neither the affinity of RseB for RseA, nor the activity ofFig. 7. Cartoon representation of RseP. The periplasmic PDZ domain plays a
role in the regulation of the activity of the protease. It may bind a glutamate-rich
region of RseA. The HEXXH and LDG residues are part of the conserved
metalloprotease active site.RseP is modulated by unfolded OMPs [60]. However, there is
the possibility that RseB may be regulated by some as yet
unknown signal. Further negative regulation of RseP was
discovered by studies with inactivated DegS, which indicated
that DegS also inhibits DegS independent proteolysis by RseP
[60]. These regulatory interactions remove noise from the σE
activation system such that small changes in OMPs are
detectable, and accidental variations in concentrations of
the components of the system do not affect the signaling
[21,33,60].
2.4. Cytosolic proteolysis of RseA
RseA and σE interact with picomolar affinity, which ensures
that degradation of RseA associated with liberation of σE is
almost entirely dependent on ATP-driven proteases [37]. These
energized proteases have the ability to unfold proteins, which
enables them to disassemble the RseA/σE complex and degrade
RseA. RseA is the most quickly degraded substrate of its
protease, ClpXP, thus substrate competition does not greatly
affect the rate of RseA degradation by ClpXP [36,37]. Although
ClpXP is the most active protease in RseA proteolysis, most of
the ATP-dependent proteases can degrade RseA in vivo [37].
Thus, in the unlikely event that ClpXP is competed away by
alternative substrates, other ATP-dependent proteases will also
degrade RseA [37]. Given that RseA is the substrate of so many
proteases, it is unlikely that any type of regulation of this
proteolysis is possible. With all of the regulatory elements in
place, the only known input that activates the series of
proteolytic events is the recognition of OMP C-termini by
DegS.
2.5. Other ECF signaling pathways similar to σE signaling
Characterized σE homologues in Gram-negative bacteria and
some homologues from Gram-positive bacteria appear to be
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these mechanisms there is almost always expression of an anti-
sigma factor that inhibits the activity of the sigma factor. Activity
of the sigma factor is often associated with the degradation of
this protein. However, not all of the components of the
regulatory systems appear to be homologous and the biochem-
ical characterization of these systems is still incomplete.
AlgU is an ECF sigma factor homologous to σE that
regulates the expression of the genes essential to the protective
mucoid phenotype in P. aeruginosa. The molecular signals that
activate AlgU are still unknown, although there are at least two
methods by which AlgU activity is induced. Under some
conditions, the AlgU pathway responds to periplasmic stress
signals similar to that of E. coli σE [62]. However, in the lungs
of cystic fibrosis patients and similar laboratory conditions, the
mucoid expressing P. aeruginosa often inactivate the anti-
sigma factor MucA through C-terminal mutations [63,64].
Although these data indicate that there are multiple
mechanisms for AlgU activation, the constituents and at least
some parts of AlgU regulation are analogous to σE regulation.
The algU mucA mucB mucC gene cluster is homologous to the
E. coli rpoE(σE) rseA rseB rseC gene cluster [61]. Similar to
RseA, MucA appears to act as an anti-sigma factor [65,66].
Conversion to the mucoid state is associated with a redistribu-
tion of AlgU from the inner membrane to the cytosol, which
suggests proteolysis of the anti-sigma factor similar to
proteolysis of RseA [67]. Truncations or alterations of the
periplasmic C-terminus of MucA that dramatically lower the
stability of MucA were found in almost all of the mutants of
mucoid isolates of P. aeruginosa in the lungs of cystic fibrosis
patients [67–69]. The RseB homologue, MucB, has a similar
but more pronounced negative regulatory role than RseB, as
mutations in MucB lead to a stronger depression of AlgU
activity [65,66]. RseP homologues AlgQ and MucD negatively
repress AlgU activity rather than play a role in activating it as
RseP does in σE activation [70]. Although a RIP protease
mechanism similar to σE activation may initiate the degrada-
tion of the anti-sigma factor MucA, no known DegS or RseP
homologues appear to play these roles in the activation of
AlgU.
The exact mechanism of AlgU activity in wild-type cells
remains elusive, but the activity of the mucAmutants is partially
understood. The instability of the MucA mutants is associated
with the activity of the PDZ domain containing periplasmic
protease Prc [71]. This protease has no effect on wild-type
MucA, but it will degrade the mutant MucAs [71]. One thought
is that the mutations in MucA leave unfolded C-terminal tails
that can be recognized by the PDZ domain of Prc [71]. It is
attractive to think that if there is a RIP protease mechanism for
activation of AlgU in wild-type cells, removal of the
periplasmic domain by Prc would allow the site 2/RIP protease
to release the cytosolic portion of MucA into the cytosol for
degradation.
In the Gram-negative bacterium Myxococcus xanthus the
sigma factor CarQ also appears to be regulated in a similar
method to σE. However, with the exception of CarQ itself
none of the regulatory elements in this system are homologousto members of the σE system. CarQ is involved in a response
to very specific envelope stress in the form of light-induced
oxidative damage. This ECF sigma factor regulates the
expression of carotenoids which protects the cell from photo-
damage [72–74]. CarQ is cotranscribed with its anti-sigma
factor, CarR, which has no similarity to RseA [3,72,74,75].
The inhibitory activity of CarR in turn is regulated by CarF,
which appears to directly or indirectly mediate the light-
induced deactivation of the CarR anti-sigma factor activity
[76]. Without homology to any known protease, CarF may
function as an anti-anti-sigma factor, as observed with the
partner switching mechanism of SpoIIAB and SpoIIAA
regulation of σF and the RsbW and RsbV proteins of σB in
Bacillus subtilis [76–78]. In these cases, the anti-anti sigma
factor interacts with the anti-sigma factor and displaces the
sigma factor. However, there is evidence that the anti-sigma
factor CarR is degraded when enough light is present for CarQ
activity [3]. This would suggest a mechanism similar to that of
σE [3].
Although Gram-positive bacteria have no periplasm with
which to detect unfolded proteins, there appears to be some
similarity between the σE type of signaling in Gram-negative
bacteria and some ECF signaling pathways in Gram-positive
bacteria. Recently an envelope stress response regulator in the
Gram-positive B. subtilis, σW, was found to be regulated in a
very similar way to σE from E. coli. It has an anti-sigma factor,
RsiW, which is degraded by the RIP protease YluC (also called
RasP). YluC can cut RsiW only after YpdC (also called PrsW)
cleaves the periplasmic domain of RsiW [79,80]. Like RseA,
the final cytoplasmic cleavage product of RsiW is also a
substrate for the ClpXP protease. However, the relationship
between RsiW and ClpXP appears to be more exclusive than
with RseA, as the proteolysis of RsiW by ClpXP is titratable by
competing substrates [81]. Another difference between the σW
and σE systems is the lack of homology between the primary
cleavage enzymes, YpdC and DegS. YpdC appears to contain
multiple transmembrane helices compared to the single
transmembrane helix of DegS. In fact, there are no homologues
of YpdC in E. coli and the three DegS homologues in B. subtilis
do not appear to be involved in this signaling mechanism [80].
Although there are significant differences between the σE
and σW signaling systems, there is an interesting similarity in
regulation. Similar to the DegS-dependent inhibition of RseP
proteolysis in the absence of signal, YluC appears to inhibit
YpdC in the absence of signal in σW regulation [80].
However, in this case the RIP protease inhibits the protease
that makes the initial cut rather than the opposite, which is
found in the regulation of σE activation in E. coli. Beyond this
difference it is remarkable that not only is the mechanism of
signaling similar for σE and σW, but there seems to be similar
regulation of the proteolysis that propagates the signal in this
pathway. With the similarities of these two ECF signaling
systems and the conservation of the RIP protease signaling
mechanism from prokaryotes to eukaryotes, the RIP protease
mechanism likely will be found in regulation of many other
ECF sigma factors in both Gram-positive and Gram-negative
bacteria.
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signaling
For comparison of signaling mechanisms, it is worth briefly
mentioning the Cpx signaling pathway, a primarily parallel but
somewhat overlapping periplasmic stress response pathway to
the σE system (for a review, see [61]). Not only are both of these
systems activated by unfolded proteins in the periplasm, these
systems also regulate some genes with similar activities.
However, from stimulus to gene activation, these systems have
completely different mechanisms. In Cpx signaling, the
unfolded proteins are recognized by CpxP, a periplasmically
located inhibitor of the signaling protein CpxA. On ligand
recognition, CpxP dissociates from CpxA, allowing CpxA to
autophosphorylate itself and to phosphorylate the cytoplasmic
effector CpxR. CpxR is not a sigma-factor. CpxR-P is a
transcriptional activator that binds to a specific site on DNA to
recruit RNA polymerase through interaction with the C-terminal
domain of its α-subunit. Thus, the methods of gene regulation
are completely different for these two very similar regulons that
are activated by similar stimuli.
3. Regulation of iron–citrate transport: activation of
factor FecI from an extracellular signal
A second type of ECF signaling, distinct from mechanisms
discussed for σE, is illustrated by the activation of FecI. For
Gram-negative bacteria, iron uptake is a serious problem. With
an additional membrane they have limited accessibility to an
already scarce resource, as iron is insoluble in the aerobic
environment [82–84]. Thus, these organisms have developed
complicated systems for detecting and acquiring precious metal
ions. Most often siderophores are used to complex the iron and
this complex is transported first into the periplasm where it may
be bound by a secondary iron binding protein. Then the iron (orFig. 8. Illustration of the FecARI signaling mechanism. Iron–citrate binding to FecA
TonB is required for signaling the presence of iron–citrate sensed by FecA to FecR in
N-terminus of FecR. RNA polymerase is then recruited to the FecA promoter afterferric siderophore) is transported across the inner membrane
into the cytoplasm.
Although the members of the iron–citrate uptake system are
not essential proteins, they must give some bacteria an
advantage because iron–citrate transport is a costly process.
Not only is energy involved in the synthesis of these proteins,
but the transport of the iron across each membrane is energized.
The outer membrane iron transport proteins associate with
TonB, which uses the proton gradient across the inner
membrane of E. coli to power the outer membrane transporter
[85,86]. Iron transport across the inner membrane also requires
energy in the form of ATP hydrolysis. Once the cell has
acquired enough iron, the production of the iron transport
machinery is repressed by the Fur repressor [87]. In iron-rich
conditions, Fur forms a complex with iron and becomes an
active repressor of the expression of iron transport genes [87].
Regulation of the iron–citrate transport genes is remarkable,
because FecA not only transports iron, it signals the extracel-
lular presence of iron–citrate to the genetic machinery in the
cytoplasm (Fig. 8) [88]. When the iron–citrate complex binds to
FecA on the outside of the cell, a signal is transferred through
FecA and its periplasmic N-terminal domain to the C-terminal
end of the inner-membrane protein FecR [91–93]. FecR then
transmits the information through the inner membrane to its N-
terminus which consequently affects FecI. FecI is activated to
recruit RNA polymerase and bind to the fec operon, thus
increasing the expression of the iron–citrate uptake genes
[94,95]. Other than FecA itself, the expressed proteins include
FecB [95], the periplasmic binding protein, and the FecC, FecD
and FecE proteins, which form an ATP-dependent ABC
transporter complex in the inner membrane [95,96]. Sequence
analysis indicates that FecA is part of a subclass of TonB-
dependent iron transporters that have N-terminal extensions
before the TonB interaction site [97,98]. It is believed that the
extensions of these other TonB-dependent proteins are likely toat the outer membrane allows TonB to recognize the TonB box region of FecA.
the inner membrane. Activated FecR in turn activates FecI, which is bound to the
binding activated FecI.
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sigma factor signaling mechanisms that are similar to FecARI.
3.1. Signaling through the iron–citrate transporter FecA
Apo- and iron–citrate bound structures of FecA by Ferguson
et al. and Yue et al. delineate the structural changes that are
likely to contribute to the signaling of the presence of iron–
citrate (Fig. 9) [90,91]. Like all known TonB-dependent iron-
siderophore transporters, FecA consists of a large 22 stranded
anti-parallel β-barrel with a plug domain N-terminal to the
barrel that folds inside the barrel thus blocking small molecule
transfer between the periplasm and the extracellular space
[90,91]. On the cell surface, large extracellular loops that are
required for both signaling and transport clamp down over the
iron–citrate as it binds to FecA [90,91,99]. This binding event
creates structural changes in FecA that extend from the
extracellular space to the periplasm [91,93]. Conformational
changes in extracellular loops 7 and 8 also induce changes in a
small loop in the plug domain (NL4), which is found in an
altered conformation on iron–citrate binding (Fig. 9) [91]. This
loop contains the RGX5YGX4GX2N motif found in TonB-
dependent transporters, suggesting its importance in signaling
the presence of substrate to TonB. Another significant
conformational change occurs upon iron–citrate binding:
residues constituting the TonB box of the transporter, involved
in a subsequent protein–protein interaction with TonB protein,
become highly mobile (and therefore disordered in the crystal
structures) upon binding iron–citrate. Similar changes in the
TonB box region have been associated with other TonB-
dependent transporters on ligand binding [100–104]. EPRFig. 9. X-ray crystal structures of FecAwith and without iron–citrate indicate a
path of structural change which may signal the presence of iron–citrate [90,91].
The β-barrel is shown in grey and is transparent in the front. The plug domain is
shown in darker grey. Changes in loop movements are indicated by the
differences in the loop structures of the apo (blue) and iron citrate bound
(magenta) FecA crystal structures.measurements on ligand bound BtuB indicate that the TonB box
moves away from the plug domain and extends into the
periplasm [105]. Disorder and lengthening of this region may be
required for recognition of the substrate bound state of the
transporter by TonB [106–108].
3.2. TonB is Required for iron–citrate signaling
Many outer membrane transporters require TonB in order
to transport substrates. TonB is thought to provide mechan-
ical energy to this set of TonB-dependent transporters, which
includes FecA. With some sequence homology to the flagel-
lar motor proteins (MotA and MotB), the inner membrane
bound TonB–ExbB–ExbD complex harnesses energy from
the proton gradient across the bacterial inner membrane in order
to create mechanical energy [109]. TonB protein reaches across
the periplasm to recognize iron–citrate bound FecA at a
specific amino acid sequence known as the TonB box
(D80A81L82T83V84) (Fig. 9) [110]. The TonB box is at the end
of the plug domain and close to the FecR binding site. Complex
crystal structures of other TonB-dependent transporters with a
TonB fragment indicate that TonB and the TonB box interact
through the addition of a β-strand of the transporter's TonB
box to a β-sheet in TonB [107,108]. Interestingly, these
structures also indicate there are interactions between TonB and
its transporters that do not involve the TonB box ([107,108].
These other TonB/transporter interactions appears to occur
whether or not the TonB box is exposed, as most TonB-de-
pendent proteins also have an affinity for TonB with or without
the ligand [111,112,107]. It appears that TonB may have
transient associations with the transporters, but until it re-
cognizes the TonB box that is exposed on ligand binding, TonB
cannot act on the transporter. It is still not clear how TonB acts
on its transporter to stimulate transport.
There is extensive evidence that suggests that TonB is not
only required for FecA mediated transport of iron–citrate into
the periplasm, but that TonB is also required for FecARI
mediated signaling. Removal of the TonB box eliminates
signaling, and specific point mutations in the TonB box can
dramatically reduce signaling [110]. Dissipation of TonB's
power source, the proton motive force (PMF) across the inner
membrane, with CCCP and DNP eliminates iron–citrate
stimulated signaling by FecA [89]. Deletion or mutations in
other components of the TonB system (ExbD or ExbB) also
abrogate signaling as well as transport [88,89]. Interestingly,
TonB independent signaling occurs in the FecA4 mutant
(L157P/N529D/R611C; located in the plug domain, extracel-
lular loop 7, and TM beta strand 17, respectively) [88].
However, with this mutant protein the transcription induction is
only 10% that of wild-type [88].
It is not clear why TonB is required for FecA mediated
signaling of the presence of iron–citrate. This dependence on
TonB suggests that the conformational change required for
signaling is energy intensive. One can rationalize an evolu-
tionary reason for the TonB requirement for FecA signaling.
Because FecA requires TonB, TonB-dependent signaling by
FecA ensures that TonB is available to assist in iron–citrate
Fig. 10. NMR structure of the signaling domain of the N-terminus of FecA
[92,93]. Mutagenesis indicates that interaction with FecR is likely to occur at the
shallow binding site proximal to the N-terminus and helices α1 and α3 (Site 1)
or along the β3 (Site 2). However, some residues that are outside of these
regions, such as T70, are important for activity.
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activity of FecA4 is low, the existence of this constitutively
active FecA mutant suggests that signaling by FecA may not
necessarily require a continuous application of energy from
TonB. During the TonB-dependent transport cycle of FecA,
FecA may adopt a transient conformation that signals the
presence of iron to FecR as part of the process of iron–citrate
transport.
3.3. FecA N-terminal extension is required for signaling to
FecR
Although ligand binding appears to disorder the TonB box
and proximal residues, NMR structures of the N-terminus of
FecA indicate that about 10 amino acids from the TonB box
the N-terminal domain are ordered [92,93]. The crystal struc-
tures of FecA were probably unable to capture the structure of
the N-terminal domain due to the flexibility of the region
between the N-terminal domain and the plug domain. The
NMR structures indicate that the N-terminal domain is highly
ordered up to residue 79 and beyond this the structure becomes
much more flexible [92,93]. The N-terminal domain has a
novel fold consisting of two α-helices side by side which are
sandwiched between two small β-sheets [92,93]. DNA se-
quence analysis of N-terminal extensions from other TonB-
dependent proteins indicates that this fold appears to be
conserved [92]; the structure of the ferric pyoverdine receptor
(FpvA), which includes its N-terminal signaling domain,
confirms the structural conservation of the signaling domain
[113]. In this structure, the linker region between the TonB box
and signaling domain was disordered, suggesting flexibility in
vivo.
The striking similarity of the signaling domains observed in
the X-ray crystal structure of the ligand bound form of FpvA
and the NMR structure of the FecA N-terminus suggests that no
structural change occurs within the N-terminus itself for
signaling [113]. One caveat is that active TonB is required for
the signaling process, and it is not included in these structures
for obvious reasons. However, it seems unlikely that TonB
would affect the structure of the N-terminus as part of signaling.
As TonB is acting mechanically on FecA to power ligand
transport, signaling is likely to be a part of the transport process.
Computer modeling of BtuB suggests that transport of the plug
bound ligand in TonB-dependent transporters can be mediated
by TonB-dependent unraveling of the plug domain through a
pulling action on the TonB box [114]. Although the exact
mechanism of TonB-dependent transport is not clear, any
movement of the TonB box mediated by TonB will cause a
movement of the N-terminus relative to the rest of FecA and
FecR. This movement would be a clear method of mechanical
signaling to FecR.
Study of mutants of both FecA and FecR indicate that FecR
interacts at a shallow depression that lies at the end of α2 and/or
along β2 (Sites 1 and 2 respectively) in the N-terminal domain
of FecA (Fig. 10) [93,115,116]. However, mutations of some
surface residues that are well outside this region also interfere
with signaling. These mutations indicate that there may be morethan one surface of contact with FecR, or some of these residues
may somehow be involved in signaling without participating in
the FecI–FecR interface. Furthermore, the N-terminus of FecA
and the C-terminus of FecR are likely to be constitutively
associated, as portions of these two proteins interact with out
any iron–citrate present in LexA hybrid repression studies
[115].
Of the FecR C-terminal periplasmic domain (residues 101–
317), only the last 80 residues are required for the interaction
with FecA [115]. Mutations that abrogate signaling cluster in
and around the conserved leucine-rich motif of FecR (247–286)
[115]. This leucine-rich region may be important for creating an
interaction surface with FecA [115]. Some mutants of the
periplasmic domain FecR are constitutively active and may
mimic the conformation of FecR that is activated by FecA.
These mutants include FecR (D138E/V197A) which is not only
constitutively active but also binds to FecA more strongly [115].
Another single missense mutant, FecR (S127F), is also
constitutively active [117].
On the other end of FecR, the constitutive activity of the
cytoplasmic N-terminal domain of FecR in comparison to its
inactive full-length form raises questions about the activation
of FecR. The cytosolic portion of FecR, FecR1–85, is
constitutively active. FecR fragments that include the
transmembrane domain and even parts of the periplasmic
domain are also constitutively active [117]. However, the
longer FecR truncation mutants that extend to residues 207
and 273 are much less active than the shorter constructs
[117]. The 273-residue construct is particularly less active.
Together these data indicate that some aspect of the C-terminus
of FecR inhibits the activity of the N-terminus of FecR. Iron–
citrate binding to FecA and the resulting structural changes may
allow FecR to undergo a conformational change that relieves the
inactivation imposed by the C-terminal end of FecR.
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across the inner membrane is not understood. With a single pass
transmembrane domain and as a monomer, it is difficult to
explain how a conformational change could be propagated from
one side of the membrane to the other. It is also difficult to
explain how the C-terminal portion(s) of FecR appears to play
an inhibitory role.
Braun et al. suggest that the signal could traverse the inner
membrane through proteolysis of FecR by RseP, the RIP
protease from the σE activation pathway [118]. RseP has wide
substrate specificity so it may cleave FecR, and RIP proteo-
lysis would be consistent with the constitutive activity of the
FecR1–85 fragment. In a mechanism similar to that of σ
E
activation, one can imagine that the activated TonB/FecA
complex may alter or displace the FecR periplasmic domain to
expose a cleavage site to an unidentified protease. Parallel to
proteolysis of the RseA periplasmic domain, removal of the
periplasmic domain of FecR may remove inhibition of RseP.
One can also imagine that activated TonB/FecA complex may
alter the structure of FecR so that FecR no longer inhibits the
RseP intramembrane protease activity. The proteolysis by
RseP may then trigger a conformational change in the FecR
N-terminus that activates FecI. Alternatively, FecI could be
inhibited by the cell membrane and hydrolysis of the tether to
the membrane would allow it to be activated.
3.4. FecR activates the sigma factor FecI
Contrary to the anti-sigma factor paradigm of ECF sigma
factor regulation, the activated anti-sigma factor FecR induces
FecI to bind the β′ subunit of RNA polymerase. Prior to
activation there is some slight anti-sigma factor activity of FecR
as Lex-hybrid inhibition studies show that inclusion of FecR
inhibits the interaction of FecI and a β′1–317 N-terminal
fragment [119]. However, unlike other anti-sigma factors,
FecR is required for full FecI activity [117]. FecR1–85, which
has been shown to constitutively signal for the increased
transcription of the FecA promoter, increases the affinity of FecI
to the β′ fragment of RNA polymerase [119]. This FecI-β′
interaction correlates with FecI activity, as the FecI mutant
which does not stimulate transcription cannot bind to β′ [119].
FecI can only perform its function and recognize the fecA
promoter as part of the holo-RNA polymerase [43]. Using a
His10-affinity tag on the β′1–317, FecI be can be copurified, and
the FecR85 can be copurified with both FecI and β′1–317 [119].
Therefore, FecR does not interfere with the FecI–RNA
polymerase interaction and together FecI, FecR and RNA
polymerase can form an activated complex.
FecR binds specifically to region 4 (σ4) of FecI. Sequential
deletions and single point mutations in FecI revealed that only
σ4 is required for FecR interaction [120]. This region is thought
to contain a helix–turn–helix motif that is critical to the
interaction with FecR [120]. Substitution of leucines with
prolines within this motif eliminates binding to FecR, but
replacing these prolines with arginines allows moderate to full
recovery of binding. These data suggest that this structure is
critical for the interaction between FecI and FecR [120]. In mostsigma factors, this region is also important for recognition of the
−35 region of the promoter [6]. However, studies of FecI
promoter interactions indicate that −35 recognition may not be
important for FecI–fecA promoter binding. Although alterations
in the −35 region were found in promoter mutants that could not
bind FecI–RNA polymerase, these alterations were also
accompanied by changes proximal to the +13 position, which
is well outside the canonical promoter region [43]. Single
substitutions in the fecA promoter near position +13 also affect
FecI binding [43]. Thus, the FecI–RNA polymerase complex is
likely to have a novel interaction with the fecA promoter DNA,
even compared to other ECF sigma factors. Perhaps this new
type of promoter interaction of the sigma factor in the context of
the holoenzyme complex allows FecR to activate FecI and
remain bound to FecI on polymerase binding.
As FecR85, FecI and β′1–317 can all interact simultaneously,
the model for activation suggests that FecR is included in the
RNA polymerase initiation complex [119]. Past models have
suggested that FecR inhibits FecI, and on activation by FecA,
FecR frees FecI in order for FecI to associate with the RNA
polymerase complex. Given that FecR, FecI, and β′ can form a
tertiary complex, and that activated FecR increases both the
affinity of FecI for β′1–317 and the activity of FecI, FecR is
likely to remain attached to FecI when FecI recruits RNA
polymerase. Although FecI would remain attached to the
membrane bound FecR, FecR would not keep the polymerase
tethered to the membrane for the duration of transcription. Only
about 10 bases are polymerized before the polymerase switches
from the transcription initiation to elongation state, and sigma
factors are released near this transition [121]. However, this
does pose an interesting problem for promoter recognition. If
FecI is tethered to the membrane by FecR it would be restricted
in its ability to find the proper promoter.
3.5. Fate of FecI
The ultimate fate of FecI likely depends on whether or not
FecR remains bound to FecI when the RNA polymerase begins
transcription. If the FecIR–RNA polymerase complex remains
intact during transcription initiation, then upon removal of FecI
from the polymerase complex, the proteolytically sensitive FecI
would likely be degraded. However it is possible that the FecIR
complex may re-form and return to its inactive state. This is of
course assuming that in the absence of iron–citrate the signaling
process is reversible, which is likely, as there is no known
covalent modification or proteolysis involved. Furthermore,
studies indicate that even on repression of FecI expression by
Fur-Fe+3, FecI is a long-lived activated species [122]. This may,
in part, be due to the continued activation and protection by
FecR. Given that FecR stabilizes FecI from proteolysis, FecI
would probably be proteolysed in the absence of the protection
by FecR [121,119]. On conclusion of the RNA polymerase
initiation step and the release of FecI, FecI may be proteolysed
if FecR does not remain attached through the whole initiation
process. Given that FecIR can form a complex with the β′
subunit of RNA polymerase, it is a distinct possibility that the
FecIR complex remains intact during transcriptional activation.
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signaling
The other TonB-dependent proteins with N-terminal ex-
tensions in various bacterial species are likely to be involved in
a similar signaling mechanism to the FecARI signaling me-
chanism. However, a genome wide search for TonB-dependent
transporters (by homology to the TonB box) and TonB-
dependent transducers (by homology to the N-terminal signal-
ing domain) indicated that the TonB-dependent signaling is the
exception rather than the rule [98] Of the 84 genomes that have
TonB-dependent receptor/transporters, only 26 of the genomes
have TonB-dependent transducers. In most of these 26
organisms, only one to six different TonB-dependent trans-
porters are present [98]. Only in three organisms were many
more TonB-dependent transducers found: Nitrosomaonas
europaea (24), P. aeruginosa (14), and Pseudomonas putida
(11) [98]. As other FecARI type signaling systems would
depend on inner membrane components similar to FecR, the
genomes were also analyzed for FecR-related proteins. There is
a tight correlation between the number of TonB-dependent
transducers and the number of FecR-like proteins. Interestingly,
this analysis indicates that although the FecARI like signaling is
found in several environmental bacteria and some pathogens,
this signaling appears to be missing in several important human
and animal pathogenic genera including Brucella, entero-
pahtogenic E. coli (EPEC), Haemophilus, Helicobacter, Neis-
seria, Salmonella, Shigella, Vibrio, and Yersinia [98].
Most systems homologous to FecI appear to be involved in
iron signaling and transport. The transporters for these systems
include: PupA, HasR, FiuA, FpvA, PubB, PbuA, BfrZ, and
BhuR [93,97,123–126]. Although these systems have the
components seen in FecARI, they may not necessarily use the
signaling components in the same way. For example, rather than
having an activating effect on its associated sigma factor, the
FecR homologue PupR only appears to have distinctly
inhibitory effect on the sigma factor PupI [127]. Similarly the
anti-sigma factor HasS only appears to have an inhibitory effect
on the sigma factor HasI in regulation of heme uptake in Ser-
ratia marcescens [125]. Similar to the FecARI system, HasI
does not regulate its own expression, but unlike the relationship
between FecI and FecR, HasI does regulate the expression of
HasS [125].
One known TonB-dependent transducer does not transport
ligand. The PrhARI system from the pathogen Ralstonia
solanacearum binds a portion of a plant cell wall and signals
the presence of the plant to the bacterium [128]. This signal
induces the hypersensitive response and pathogenicity genes
that are essential for its interaction with non-host plants and
induction of the type III secretion system required for disease
development in host plants [128].
Some TonB-dependent receptors/transporters also contain an
extra domain called the Oar domain [98]. When present, the Oar
domain occurs between the N-terminal extension and the TonB
box [98]. The role of this domain is not yet clear. Although the
Oar domain can be found in proteins without the N-terminal
signaling domain, it is interesting to consider that the Oardomain may promote protein–protein interactions that may
affect regulation of the FecARI type signaling.
4. Conclusions
Signaling in ECF activation takes an interesting variety of
forms. In this review, we have discussed the two major groups of
signaling mechanisms represented by the σE and the FecI
signaling. Some of the associationswith these groups are based on
what appear to be somewhat similar mechanisms rather than
homology, like the association of CarQ signaling with σE
signaling. Although the components of the CarQ signaling
pathway have no homology to the components of theσE signaling
pathway, the evidence that activation of CarQ is concomitant with
anti-sigma factor degradation suggests a mechanism similar to
that of the regulation of σE. Most other systems of ECF
regulation, especially in Gram-negative bacteria, appear to have
components that are homologous to components of either the σE
or the FecI signaling systems. However, these components are
often not used identically and illustrate the great diversity of the
use of the components of the signaling systems.
Comparison of the σE-like and the FecI-like signaling
systems suggests that one simple explanation for some of their
differences is that these systems communicate conditions from
different cellular locations. The FecARI system signals the
presence of extracellular iron–citrate through two membranes
and the intervening periplasmic space. The FecARI model of
signaling is appropriate for signaling the presence of extra-
cellular small molecules that only reach the periplasm by
transport, such as chelated iron in the case of FecARI. The
two-component (Cpx-like) and the RIP protease (σE-like)
systems that recognize periplasmic stimuli could possibly be
used for signaling the presence of the extracellular small
molecules. However, as periplasmic detection of the extra-
cellular molecules would first require transport, this method of
detection and signaling would not be as efficient as the
FecARI-like system. This is especially the case for the PrhARI
signaling system from R. solanacearum, because this system
detects an integral part of an intact plant cell wall which cannot
enter into the periplasm.
The σE-like activation pathway is appropriate for recogni-
tion of periplasmic stimuli in Gram-negative bacteria or
external stimuli in Gram-positive bacteria. Because the
detection of the periplasmic stimuli of σE could be detected
by a two-component signaling system such as Cpx, activation
of many of the regulons with the σE-like pathway may
alternatively be regulated by a two-component signaling
pathway. It is not clear what pressures determine why a
regulon would be controlled by one or the other, thus an
interchangeability of these signaling systems is suggested. This
ambiguity is partly reflected by a σE homologue in the Gram-
positive bacterium S. coelicolor A3(2), which appears to be
regulated by a two-component system [18]. Although Gram-
positive bacteria do not have a periplasm, σE-like RIP protease
mechanisms appear to play a role in regulation of ECF sigma
factors in these organisms as well. The σW signaling system
from B. subtilis contains an anti-sigma factor and a RIP
1942 B.E. Brooks, S.K. Buchanan / Biochimica et Biophysica Acta 1778 (2008) 1930–1945protease. Given the universality of the RIP protease mecha-
nism, it should be no surprise that ECF signaling systems in
Gram-positive bacteria use σE-like RIP protease mechanisms.
An almost universal commonality to ECF signaling, espe-
cially in Gram-negative bacteria, is the use of anti-sigma factors.
The two major mechanisms of ECF sigma factor regulation and
the variations all use anti-sigma factors. Anti-sigma factors are
probably retained for a number of reasons. Two coupled reasons
are that the anti-sigma factor protects the sigma factor from
degradation and the sigma factor is ready to act as soon as it is
activated or released. The use of an anti-sigma factor as a
signaling component also lends itself to a variety of regulatory
mechanisms which are not limited to those presented in this
review [19].
Another commonality in signaling in these systems is protein
recognition through addition of a β-strand of one protein into a
β-sheet in the other. In the ECF signaling mechanisms these
interactions are primarily mediated by PDZ domains. The σE
signaling mechanism contains PDZ domain interactions with
both DegS-OMP recognition as well as regulation of RseP. The
Prc protease that plays a role in the regulation of AlgU in mutant
P. aeruginosa also contains a PDZ domain which may play a
role in AlgU activity. In the FecARI signaling system, TonB
interacts with the TonB box through β-strand addition.
In summary, ECF sigma factor signaling is extremely
diverse, most likely in order to address different types of
signals from various locations. The signaling mechanisms often
use similar components, but in different signaling systems these
components may be used in different ways.
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